EPC Biological Product Vaccine Production Line
Biological products/vaccine production line
The first phase investment is 150 million yuan. Four vaccine production lines have been built and passed the national GMP dynamic acceptance in September 2016. It can produce 7 billion live vaccines and 1 billion ml inactivated vaccines for poultry annually. The second phase of the project is planned to invest 650 million yuan. It is planned to build 8 production lines for animal biological products, with an annual total output value of 1.6 billion yuan.
The project includes indoor decoration, ventilation and air conditioning, electrical construction, process water supply and drainage and automation engineering.